A simplified latex bead immunoagglutination test is described employing the use of commercial antibody. It is practicable, reproducible and valid in screening for ‘microalbuminuria’ in diabetic patients. Although it is recommended as a side-room test its use should be supplemented where indicated by laboratory-based measurements.
References
1.
MogensenCEChristensenCK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med1984; 311: 89–93.
2.
VibertiGCHillRDJarrettRJ. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1982; i: 1430–2.
3.
KROC Collaborative Study.Blood glucose control and the evolution of diabetic retinopathy and albuminuraemia: A multicentre radomized feasibility trial. N Engl J Med1985; 312: 617–21.
4.
PedersonEBMogensenCE. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Invest1976; 36: 231–7.
5.
MarksV. Clinical biochemistry nearer the patient. Br Med J1983; 286: 1166–7.
6.
VibertiGCVerganiD. Detection of Potentially reversible diabetic albuminuria: A three-drop agglutination test for urinary albumin at low concentration. Diabetes1982; 31: 973–5.
7.
WattsGFBennettJERoweDR. An assessment of immunochemical methods for the determination of urinary albumin at low concentrations. Clin Chem1986; 32: 1544–8.
8.
AbramsonJH. In: Survey Methods in Community Medicine.London: Churchill Livingstone, 1984; 134–47.
9.
WattsGFShawKMPolakA. The use of random urine samples to screen for microalbuminuria in the diabetic clinic. Practical Diabetes1986; 3: 86–8.
10.
MogensenCW. Microalbuminuria predicts clinical proteinuria and early mortality in maturity—onset diabetes. N Engl J Med1984; 310: 356–60.
11.
WattsGFKhanKMorrisRW. Prevalence of microalbuminuria in a clinic population of insulin-dependent diabetics: Relation to age of onset and duration of diabetes. (Abstract). Diabetic Medicine1987 (in press).
